Inhibition of oncogenic kras-induced GM-CSF production and function
US9901079B2 · kind B2 · utility
1Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 20, 2012 |
| Grant date | Feb 27, 2018 |
| Priority date | — |
| Expiry date | Aug 20, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57484
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention is directed to methods of inhibiting tumor growth in a subject. The present invention is further directed to methods of diagnosing cancer in a subject and identifying a suitable course of treatment for the subject based on the diagnosis. The present invention is also directed to an orthotopic animal model of pancreatic cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.